NB BIOVILDA M (Metformin (500mg) + Vildagliptin (50mg))

NB BIOVILDA M 500 is a carefully designed tablet that can be taken either once or twice daily, intended for individuals diagnosed with Type 2 Diabetes whose blood glucose levels are not sufficiently managed by Metformin alone, or for those who need a more extensive approach to meet their glycemic targets. This medication combines two effective mechanisms to provide comprehensive blood sugar management over a 24-hour period. Its use can significantly lower the chances of developing serious complications associated with diabetes, including issues related to the kidneys, nerves, eyes, heart, and the risk of strokes. The formulation includes Metformin, which is known for its ability to decrease glucose production in the liver and enhance insulin sensitivity in muscle and fat tissues, while also slightly reducing glucose absorption in the intestines. The second active ingredient, Vildagliptin, functions as a DPP-4 inhibitor, which helps to maintain the activity of incretin hormones that facilitate insulin release when glucose levels are high, thereby managing blood sugar without increasing the risk of hypoglycemia. The synergistic effect of these components provides superior control of blood sugar levels, resulting in significant decreases in HbA1c, indicating better long-term glucose management. Furthermore, this combination is designed to minimize the risk of dangerously low blood sugar levels while potentially being weight neutral or even supporting modest weight loss. By integrating two essential anti-diabetic medications into one tablet, NB BIOVILDA M 500 simplifies the treatment regimen, thus promoting adherence to the prescribed therapy. For optimum safety and effectiveness, it is crucial to follow the prescribed dosage and maintain regular monitoring of blood glucose levels.